Web Results

www.pacermonitor.com/public/case/22927050/QUARLES_v_ASTRAZENECA_PHARMACEUTICALS_LP_et_al

Nov 6, 2017 ... QUARLES v. ASTRAZENECA PHARMACEUTICALS LP et al (2:17-cv-11219), New Jersey District Court, Filed: 11/06/2017 - PacerMonitor ...

www.pacermonitor.com/public/case/22954727/HAMPTON_v_ASTRAZENECA_PHARMACEUTICALS_LP_et_al

Nov 9, 2017 ... HAMPTON v. ASTRAZENECA PHARMACEUTICALS LP et al (2:17-cv-11480), New Jersey District Court, Filed: 11/09/2017 - PacerMonitor ...

journals.lww.com/md-journal/Fulltext/2017/09290/Comparative_effectiveness_and_acceptability_of_the.33.aspx

Sep 1, 2017 ... Kaltenbach T, Crockett S, Gerson LB. Are lifestyle ... Friedenberg FK, Hanlon A, Vanar V, et al. Trends in ... AstraZeneca Pharmaceuticals LP.

www.ncbi.nlm.nih.gov/pmc/articles/PMC2996146

Tinkelman et al found that the strongest differential indicators were increasing age and pack-years of .... This support was funded by Novartis Pharma AG. Go to:  ...

www.ncbi.nlm.nih.gov/pmc/articles/PMC5626283

Sep 29, 2017 ... [9] Kaltenbach T, Crockett S, Gerson LB. ... [13] Friedenberg FK, Hanlon A, Vanar V, et al. Trends in ... AstraZeneca Pharmaceuticals LP.

www.ncbi.nlm.nih.gov/pmc/articles/PMC5466180

P.G.G. was a speaker for AstraZeneca, GlaxoSmithKline, and Novartis. ... Bellia V , Battaglia S, Catalano F, Scichilone N, Incalzi RA, Imperiale C, Rengo ..... Boulet LP, Cruz AA, Drazen JM, Haahtela T, Hurd SS, Inoue H, de Jongste JC, et al. ... Melbye H, Medbø A, Crockett A. The FEV1/FEV6 ratio is a good substitute for the  ...

www.nejm.org/doi/full/10.1056/NEJMoa1105482

Sep 26, 2011 ... Original Article from The New England Journal of Medicine — Changes in Forced Expiratory Volume in 1 Second over Time in COPD.

doa.alaska.gov/apoc/pdf/2005EmployerDirectory.pdf

Nov 21, 2005 ... Marilyn Crockett. Employee. Oil & Gas ..... V. Kent Dawson. Professional. Nenana ... AstraZeneca Pharmaceuticals LP ..... Merrell Lynch, et al.

www.atsjournals.org/doi/pdf/10.1164/rccm.2603005

(54) showed that acetaminophen, a drug that reduces antioxidant capacity in ..... meetings, and has received lecture fees from AstraZeneca, Boehringer, Chiesi ... Boyd CM, Darer J, Boult C, Fried LP, Boult L, Wu AW. .... R, Millar A, Donnelly SC, Keatings V, MacNee W, et al. ..... Cranston JM, Crockett AJ, Moss JR, Alpers JH.